Allergan and Richter Announce Positive Topline Results from Phase 3 Study of Cariprazine for the Treatment of Bipolar I Depression

Source :: Plus Company Updates. December 19, 2017
Publication Year :: 2017
Abstract: Coolock: Allergan Pharmaceutical company has issued the following news release: DUBLIN and BUDAPEST, Hungary, Dec. 18, 2017 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Gedeon [...]

Subjects :: Allergan PLC -- Product development
Pharmaceutical industry -- Product development
Bipolar disorder -- Drug therapy
General interest
News, opinion and commentary

Tools